Cargando…

Limited long‐term treatment persistence of first anti‐TNF therapy in 538 patients with inflammatory bowel diseases: a 20‐year real‐world study

BACKGROUND: Anti‐TNF antibodies were the first biologic treatment option for patients with inflammatory bowel diseases. AIMS: To assess length of treatment persistence of first anti‐TNF therapy and influencing factors used in the standard care of patients with inflammatory bowel diseases. METHODS: S...

Descripción completa

Detalles Bibliográficos
Autores principales:	Blesl, Andreas, Binder, Lukas, Högenauer, Christoph, Wenzl, Heimo, Borenich, Andrea, Pregartner, Gudrun, Berghold, Andrea, Mestel, Sigrid, Kump, Patrizia, Baumann‐Durchschein, Franziska, Petritsch, Wolfgang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Treatment Persistence with Anti‐tnf Agents in IBD
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8453765/ https://www.ncbi.nlm.nih.gov/pubmed/34151449 http://dx.doi.org/10.1111/apt.16478

Ejemplares similares

Loss of response to anti‐TNFα agents depends on treatment duration in patients with inflammatory bowel disease
por: Schultheiss, Johannes P. D., et al.
Publicado: (2021)

Targeted versus universal tuberculosis chemoprophylaxis in 1968 patients with inflammatory bowel disease receiving anti‐TNF therapy in a tuberculosis endemic region
por: Ye, Lingna, et al.
Publicado: (2020)

Understanding anti‐TNF treatment failure: does serum triiodothyronine‐to‐thyroxine (T3/T4) ratio predict therapeutic outcome to anti‐TNF therapies in biologic‐naïve patients with active luminal Crohn's disease?
por: Lin, Simeng, et al.
Publicado: (2022)

The paradigm shift in treatment from Covid-19 to oncology with mRNA vaccines
por: Wei, Jiao, et al.
Publicado: (2022)

Therapeutic cancer vaccines: From biological mechanisms and engineering to ongoing clinical trials
por: Sobhani, Navid, et al.
Publicado: (2022)

Factors Associated with Response to Systemic Corticosteroids in Active Ulcerative Colitis: Results from a Prospective, Multicenter Trial
por: Blesl, Andreas, et al.
Publicado: (2023)

Immunosuppressive drugs : developments in anti-rejection therapy
Publicado: (1994)

Antibioterapia en porcino : enfoque práctico
por: Fraile, Lorenzo
Publicado: (2016)

Directed Search of Anti-inflammatory Agents Among (3H-Quinazoline-4-ylidene)hydrazides of N-protected Amino acids and their Heterocyclization Products
por: Martynenko, Yulya, et al.
Publicado: (2020)

The Impact of Inflammatory Profile on Selenium Levels in Hemodialysis Patients
por: Bacci, Marcelo R., et al.
Publicado: (2020)

Anti-inflammatory Property of AMP-activated Protein Kinase
por: Noor, Humaira B., et al.
Publicado: (2020)

MECA : mejora de la calidad de los antimicrobianos : recomendaciones SEQ /
Publicado: (2006)

Dictionary of antibiotics and related substances
Publicado: (1988)

Pharmaceutical microbiology
Publicado: (1998)

Terapéutica antimicrobiana /
por: Biro, Carlos E., 1932-
Publicado: (1980)

Infectología clínica /
Publicado: (2008)

IBD LIVE Case Series–Case 2: Previous Cancer in a Patient with Crohn's Disease: Is It Appropriate to Use Biologics and Immunosuppressants for IBD Treatment?
por: Le, Peter N., et al.
Publicado: (2015)

A Mobile Infliximab Dosing Calculator for Therapy Optimization in Inflammatory Bowel Disease
por: Piester, Travis, et al.
Publicado: (2018)

Mendelian Disease Associations Reveal Novel Insights into Inflammatory Bowel Disease
por: Han, Lichy, et al.
Publicado: (2018)

The Association Between Sustained Poor Quality of Life and Future Opioid Use in Inflammatory Bowel Disease
por: Anderson, Alyce, et al.
Publicado: (2018)

Incidence, prevalence and clinical outcome of anaemia in inflammatory bowel disease: a population‐based cohort study
por: Eriksson, Carl, et al.
Publicado: (2018)

Outcomes of Pregnancies With Maternal/Paternal Exposure in the Tofacitinib Safety Databases for Ulcerative Colitis
por: Mahadevan, Uma, et al.
Publicado: (2018)

Infliximab for Crohn’s Disease: More Than 13 Years of Real-world Experience
por: Lichtenstein, Gary R, et al.
Publicado: (2018)

What Is the Risk of Progressive Multifocal Leukoencephalopathy in Patients With Ulcerative Colitis or Crohn’s Disease Treated With Vedolizumab?
por: Card, Timothy, et al.
Publicado: (2018)

Development of the IBD Disk: A Visual Self-administered Tool for Assessing Disability in Inflammatory Bowel Diseases
por: Ghosh, Subrata, et al.
Publicado: (2017)

Communication Between Physicians and Patients with Ulcerative Colitis: Reflections and Insights from a Qualitative Study of In-Office Patient–Physician Visits
por: Rubin, David T., et al.
Publicado: (2017)

Risk of dementia in patients with inflammatory bowel disease: a Danish population‐based study
por: Rønnow Sand, Jakob, et al.
Publicado: (2022)

Giving anti-VEGF injections: an update from Burundi
por: Niyonzima, Jean Claude
Publicado: (2023)

Management of Recurrent Clostridioides Infection: A Difficile Problem in Inflammatory Bowel Disease Patients
por: Lam, Angela Y., et al.
Publicado: (2020)

Going Viral: Management of IBD in the Era of the COVID-19 Pandemic
por: Gutin, Liat S., et al.
Publicado: (2020)

Opportunistic Knocks: A Gardener with Ulcerative Colitis and New Pulmonary Nodules
por: Canakis, Andrew, et al.
Publicado: (2023)

Lower Extremity Palpable Purpura in a Patient with Quiescent Inflammatory Bowel Disease
por: Darlington, Kimberly, et al.
Publicado: (2023)

Drug survival of anti‐TNF agents compared with vedolizumab as a second‐line biological treatment in inflammatory bowel disease: results from nationwide Swedish registers
por: Rundquist, Sara, et al.
Publicado: (2020)

Mucosal IL13RA2 expression predicts nonresponse to anti‐TNF therapy in Crohn's disease
por: Verstockt, Bram, et al.
Publicado: (2019)

Terapéutica antimicrobiana/
por: Biro, Carlos E., 1932-
Publicado: (1972)

How often are interventions in cluster-randomised controlled trials of complex interventions in general practices effective and reasons for potential shortcomings? Protocol and results of a feasibility project for a systematic review
por: Siebenhofer, Andrea, et al.
Publicado: (2016)

A novel hybrid left renal vein transposition and endovascular stenting technique for the treatment of posterior nutcracker syndrome
por: Stawiarski, Kristin, et al.
Publicado: (2017)

Transposition of the persistent sciatic artery for lower limb revascularization after resection of an embolizing proximal sciatic artery aneurysm
por: Feer, Rudolf, et al.
Publicado: (2017)

Safety and efficacy of a modified HeRO dialysis device in achieving early graft cannulation: A single-institution experience
por: Perry, John W., et al.
Publicado: (2017)

A Case of Persistent Right Ventricular Failure after Rapid Decompression of a Large Chronic Pericardial Effusion
por: Klimis, Harry, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_f7dbueesspgk3s6qmu7mu4kl7e